Company Monitoring Page for Alnylam

job ratings for Alnylam

11/25/24
industry:
Pharma/biotech
company:
Alnylam
job rating:
1
Micromanagment and a sense of distrust. Backstabbing aggressive team mates. Culture of not feeling free to speak up with different opinions. Punitive managers.

latest headlines for company on cafepharma

5 FDA decisions to watch in the first quarter of 2025
BioPharma Dive
Mon, 01/6/25 - 06:54 pm
Tags:
FDA, Vertex Pharmaceuticals, non-opioid pain treatments, suzetrigine, GSK, vaccines, MenABCWY, meningitis, Alnylam, vutrisiran, transthyretin amyloid cardiomyopathy, Soleno, diazoxide choline, Prader Willi syndrome, Sanofi, hemophilia, fitusiran
Alnylam cashes in priority review voucher to catch up to BridgeBio in ATTR-CM race
First Word Pharma
Tue, 11/26/24 - 11:04 am
Tags:
Alnylam, FDA, RNAi, vutrisiran, ATTR-CM
Alnylam boots Type 2 diabetes asset from haunted house
Fierce Biotech
Fri, 11/1/24 - 11:09 am
Tags:
Alnylam, RNAi, type 2 diabetes
Alnylam agrees to drop patent lawsuit against Moderna over Covid-19 vaccine
Reuters
Sun, 10/6/24 - 10:50 pm
Tags:
Alnylam, Moderna Therapeutics, legal, patents, vaccines
Alnylam’s vutrisiran aces ATTR cardiomyopathy readout
Pharmaphorum
Mon, 06/24/24 - 10:52 am
Tags:
Alnylam, RNAi, vutrisiran, ATTR, cardiomyopathy
Ahead of Alnylam's key heart disease readout, experts say Pfizer rival would be hard to displace
Fierce Pharma
Mon, 04/22/24 - 06:01 pm
Tags:
Alnylam, Pfizer, Amvuttra, ATTR-CM, tafamidis
Alnylam changes to heart drug trial spark doubts, sinking shares
BioPharma Dive
Thu, 02/15/24 - 07:13 pm
Tags:
Alnylam, clinical trials, vutrisiran, ATTR
Alnylam Publishes Phase III ATTR-CM Data for Patisiran After FDA Rejection
BioSpace
Thu, 10/26/23 - 10:39 am
Tags:
Alnylam, Patisiran, clinical trials, FDA, ATTR with cardiomyopathy
Interest in RNA Editing Accelerates as Therapies Approach the Clinic
BioSpace
Wed, 10/18/23 - 11:37 am
Tags:
RNA editing, Alnylam, Shape Therapeutics, Eli Lilly, ProQR Therapeutics
Alnylam CEO, ‘disappointed’ with FDA’s Onpattro rejection, pivots to the future
Pharma Voice
Thu, 10/12/23 - 05:32 pm
Tags:
Alnylam, Pharma CEOs, Yvonne Greenstreet, FDA, Onpattro
FDA denies expanded approval for Alnylam RNA drug
BioPharma Dive
Mon, 10/9/23 - 10:15 am
Tags:
Alnylam, FDA, RNA, Patisiran, ATTR amyloidosis
With FDA nod for rare disease drug Rivfloza, Novo Nordisk eyes showdown with Alnylam
Fierce Pharma
Mon, 10/2/23 - 06:36 pm
Tags:
Novo Nordisk, Rivfloza, FDA, primary hyperoxaluria type 1, RNAi, Alnylam
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
Tags:
FDA, Alnylam, Onpattro, ATTR amyloidosis, Vertex Pharmaceuticals, CRISPR Therapeutics, exa-cel, Bluebird Bio, Zynteglo, sickle cell disease, Bristol Myers Squibb, 2seventy bio, Abecma, Multiple Myeloma, Amgen, Lumakras, non-small cell lung cancer, Pfizer, estrasimod, ulcerative colitis
Pfizer's 'entrenched' tafamidis franchise will be tough to challenge for Alnylam, BridgeBio: analysts
Fierce Pharma
Mon, 09/18/23 - 08:01 pm
Tags:
Pfizer, BridgeBio, Alnylam, FDA, clinical trials, ATTR-CM, physicians, tafamidis
Despite FDA doubts, Alnylam wins expert backing for Onpattro expansion into rare heart disease
Fierce Pharma
Thu, 09/14/23 - 09:59 am
Tags:
Alnylam, FDA, Onpattro, ATTR-CM
FDA Questions Efficacy of Alnylam’s Drug in ATTR-CM Ahead of Adcomm Meeting
BioSpace
Tue, 09/12/23 - 07:06 pm
Tags:
Alnylam, FDA, ATTR-CM, Onpattro
Roche Sees Return on $310M Investment with Alnylam’s Phase II Hypertension Win
BioSpace
Thu, 09/7/23 - 10:49 pm
Tags:
Alnylam, Roche, PAH, zilebesiran, clinical trials
Agios and Alnylam sign agreement for siRNA candidate
Pharmaceutical Business Review
Fri, 08/4/23 - 12:09 pm
Tags:
Agios Pharmaceuticals, Alnylam, siRNA, polycythemia vera
Roche, Alnylam Ink Potential $2.8B RNAi Partnership for Hypertension
BioSpace
Mon, 07/24/23 - 11:29 am
Tags:
Roche, Alnylam, RNAi, hypertension, zilebesiran
AAIC: First Clinical Data from an RNAi Therapeutic for Alzheimer’s Continue to Impress
BioSpace
Tue, 07/18/23 - 11:50 am
Tags:
AAIC, Alnylam, RNAi, Alzheimer's disease, ALN-APP, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.